Ultima Genomics

Ultima Genomics

Private
Newark, CaliforniaHealthcare & Life Scienceshttps://www.ultimagenomics.com

Last Round

Early Funding

5/31/2022

Total Funding Raised

$602.2M

Company Overview

Ultima Genomics is a biotechnology company that develops genome-scale sequencing technology to provide analytical services to enterprises, utilizing an open substrate for low-cost, high-throughput sequencing while leveraging specialized hardware and machine learning for accurate and efficient results.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Precision Medicine, Semiconductors

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales

AI Layer

Non-AI

Keywords

low-cost sequencinggenome sequencinghigh-throughput sequencingDNA sequencing platform$100 genomenext-generation sequencingNGSsequencersemiconductor sequencingwhole-genome sequencingsingle-cell analysisliquid biopsyoncology testingpopulation genomicsminimal residual diseaseMRDmulti-omics researchsequencing consumablesbioinformatics pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ultima Genomics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Ultima Genomics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early Funding5/31/2022

Key People

Founding team and executive leadership

Gilad Almogy

Founder And CEO

Founding Team

David Peoples

Chief Financial Officer

Executive Team

Ultima Genomics Investors

Notable investors and investment history

InvestorRounds
Andreessen HorowitzEarly Funding
Khosla VenturesEarly Funding
NIH RADxGrant
Playground GlobalEarly Funding
Founders FundEarly Funding
D1 Capital PartnersEarly Funding
aMoonEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 26, 2026

    Launched the UG200 Series, a next-generation sequencing platform.

  • Feb 25, 2026

    Presented technologies at the AGBT Conference on February 25, 2026.

Ultima Genomics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ultima Genomics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ultima Genomics's valuation, stock price, and market status.

Firmographic Details

HeadquartersNewark, California
Employee Range304
Year Founded2016
Last Funding5/31/2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.